{"transactions":[{"id":4628556,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-10-02T23:56:07.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":113,"price":219.8037,"value":24837.8181,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 3rd quarter 2026 retainer fees."}],"balance_after":11143,"source":{"system":"sec-edgar","filing":"0001110803-26-000180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446989/000111080326000180/form4.xml","form_type":"4"}},{"id":718913,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-02T22:22:10.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":167,"price":149.1868,"value":24914.1956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 2nd quarter 2026 retainer fees."}],"balance_after":11030,"source":{"system":"sec-edgar","filing":"0001110803-26-000147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000147/form4.xml","form_type":"4"}},{"id":766535,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-22T21:14:58.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2072,"price":144.83,"value":300087.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date."}],"balance_after":10863,"source":{"system":"sec-edgar","filing":"0001110803-26-000119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000119/form4.xml","form_type":"4"}},{"id":785477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":19830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":19830},"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":785476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":11004,"price":79.96,"value":879879.84,"ownership":{"direct":true},"balance_after":46740,"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":785475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":19830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":57744,"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":787481,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:34.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1661,"price":82.76,"value":137464.36,"ownership":{"direct":true},"balance_after":37914,"source":{"system":"sec-edgar","filing":"0001225208-26-005047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005047/doc4.xml","form_type":"4"}},{"id":787480,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:34.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1373,"price":83.2,"value":114233.6,"ownership":{"direct":true},"balance_after":39575,"source":{"system":"sec-edgar","filing":"0001225208-26-005047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005047/doc4.xml","form_type":"4"}},{"id":792672,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-05T23:08:09.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001225208-26-004969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004969/doc4.xml","form_type":"4"}},{"id":792671,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T23:08:09.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":11131,"price":82.91,"value":922871.21,"ownership":{"direct":true},"balance_after":40948,"source":{"system":"sec-edgar","filing":"0001225208-26-004969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004969/doc4.xml","form_type":"4"}},{"id":792670,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T23:08:09.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":59.2567,"value":770337.1,"ownership":{"direct":true},"balance_after":52079,"source":{"system":"sec-edgar","filing":"0001225208-26-004969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004969/doc4.xml","form_type":"4"}},{"id":792669,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T23:08:09.000Z","date":"2026-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":620,"price":83.98,"value":52067.6,"ownership":{"direct":true},"balance_after":39079,"source":{"system":"sec-edgar","filing":"0001225208-26-004969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004969/doc4.xml","form_type":"4"}},{"id":811830,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-04-09T23:34:07.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001225208-26-004476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004476/doc4.xml","form_type":"4"}},{"id":811829,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T23:34:07.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":8324,"price":79.7866,"value":664143.6584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.210 to $80.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39699,"source":{"system":"sec-edgar","filing":"0001225208-26-004476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004476/doc4.xml","form_type":"4"}},{"id":811828,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T23:34:07.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":4676,"price":80.4963,"value":376400.6988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $80.225 to $80.750. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48023,"source":{"system":"sec-edgar","filing":"0001225208-26-004476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004476/doc4.xml","form_type":"4"}},{"id":811827,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T23:34:07.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":59.2567,"value":770337.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."}],"balance_after":52699,"source":{"system":"sec-edgar","filing":"0001225208-26-004476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004476/doc4.xml","form_type":"4"}},{"id":820672,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-02T22:32:26.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":190,"price":131.5473,"value":24993.987,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 1st quarter 2026 retainer fees."}],"balance_after":8791,"source":{"system":"sec-edgar","filing":"0001110803-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000084/form4.xml","form_type":"4"}},{"id":849421,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-03-11T21:15:11.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001225208-26-003539","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003539/doc4.xml","form_type":"4"}},{"id":849420,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:15:11.000Z","date":"2026-03-11","kind":"sale","planned":true,"acquired":false,"shares":7901,"price":85.2079,"value":673227.6179,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $84.865 to $85.790. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39699,"source":{"system":"sec-edgar","filing":"0001225208-26-003539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003539/doc4.xml","form_type":"4"}},{"id":849419,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:15:11.000Z","date":"2026-03-11","kind":"sale","planned":true,"acquired":false,"shares":5099,"price":84.4613,"value":430668.1687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.865 to $84.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47600,"source":{"system":"sec-edgar","filing":"0001225208-26-003539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003539/doc4.xml","form_type":"4"}},{"id":849418,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:15:11.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":59.2567,"value":770337.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."}],"balance_after":52699,"source":{"system":"sec-edgar","filing":"0001225208-26-003539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003539/doc4.xml","form_type":"4"}},{"id":902033,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:16:03.000Z","date":"2026-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":199,"price":75.87,"value":15098.13,"ownership":{"direct":true},"balance_after":39699,"source":{"system":"sec-edgar","filing":"0001225208-26-001987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001987/doc4.xml","form_type":"4"}},{"id":952751,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:47:12.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":212,"price":117.6298,"value":24937.5176,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 4th quarter 2025 retainer fees."}],"balance_after":8601,"source":{"system":"sec-edgar","filing":"0001110803-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000002/form4.xml","form_type":"4"}},{"id":976651,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-12-09T22:01:36.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39000,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001225208-25-009797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009797/doc4.xml","form_type":"4"}},{"id":976650,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-09T22:01:36.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":7700,"price":84.4691,"value":650412.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.09 to $85.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39898,"source":{"system":"sec-edgar","filing":"0001225208-25-009797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009797/doc4.xml","form_type":"4"}},{"id":976649,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-09T22:01:36.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":7700,"price":59.2567,"value":456276.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."}],"balance_after":47598,"source":{"system":"sec-edgar","filing":"0001225208-25-009797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009797/doc4.xml","form_type":"4"}},{"id":1004208,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-11-10T23:07:03.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46700,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001225208-25-009067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009067/doc4.xml","form_type":"4"}},{"id":1004207,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-10T23:07:03.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":10026,"price":83.0201,"value":832359.5226,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $82.270 to $83.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39898,"source":{"system":"sec-edgar","filing":"0001225208-25-009067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009067/doc4.xml","form_type":"4"}},{"id":1004206,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-10T23:07:03.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":2974,"price":83.2999,"value":247733.9026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.270 to $83.415. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49924,"source":{"system":"sec-edgar","filing":"0001225208-25-009067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009067/doc4.xml","form_type":"4"}},{"id":1004205,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-10T23:07:03.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":59.2567,"value":770337.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025."}],"balance_after":52898,"source":{"system":"sec-edgar","filing":"0001225208-25-009067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009067/doc4.xml","form_type":"4"}},{"id":1027853,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-02T20:06:14.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":252,"price":99.1666,"value":24989.9832,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 3rd quarter 2025 retainer fees."}],"balance_after":8389,"source":{"system":"sec-edgar","filing":"0001110803-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080325000063/form4.xml","form_type":"4"}},{"id":1096060,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-02T20:26:43.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":307,"price":81.1998,"value":24928.3386,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 2nd quarter 2025 retainer fees."}],"balance_after":8137,"source":{"system":"sec-edgar","filing":"0001127602-25-018667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225018667/form4.xml","form_type":"4"}},{"id":1135805,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-23T21:03:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date."}],"balance_after":7830,"source":{"system":"sec-edgar","filing":"0001127602-25-015500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225015500/form4.xml","form_type":"4"}},{"id":1140877,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-20T20:20:39.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1070,"price":83.62,"value":89473.4,"ownership":{"direct":true},"balance_after":4050,"source":{"system":"sec-edgar","filing":"0001127602-25-015019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225015019/form4.xml","form_type":"4"}},{"id":1152751,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-12T23:30:31.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1200,"price":73.68,"value":88416.0,"ownership":{"direct":true},"balance_after":39898,"source":{"system":"sec-edgar","filing":"0001225208-25-004996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004996/doc4.xml","form_type":"4"}},{"id":1154309,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-09","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154308,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":13400,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":13400},"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154307,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":75200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":75200,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":75200},"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154306,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-09","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":74.4031,"value":837034.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $74.12 to $74.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":41098,"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154305,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-09","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":45.2767,"value":509362.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."}],"balance_after":52348,"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154304,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":41098,"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1154303,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:12.000Z","date":"2025-05-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":1406,"price":74.92,"value":105337.52,"ownership":{"direct":true},"balance_after":27698,"source":{"system":"sec-edgar","filing":"0001225208-25-004942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004942/doc4.xml","form_type":"4"}},{"id":1159947,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-05T23:28:24.000Z","date":"2025-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":648,"price":75.65,"value":49021.2,"ownership":{"direct":true},"balance_after":29104,"source":{"system":"sec-edgar","filing":"0001225208-25-004765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004765/doc4.xml","form_type":"4"}},{"id":1159946,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-05T23:28:24.000Z","date":"2025-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":635,"price":75.65,"value":48037.75,"ownership":{"direct":true},"balance_after":29752,"source":{"system":"sec-edgar","filing":"0001225208-25-004765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004765/doc4.xml","form_type":"4"}},{"id":1186875,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-01T20:50:48.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":229,"price":104.9218,"value":24027.0922,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 1st quarter 2025 retainer fees."}],"balance_after":5120,"source":{"system":"sec-edgar","filing":"0001127602-25-010802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225010802/form4.xml","form_type":"4"}},{"id":1191485,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-03-26T20:45:26.000Z","date":"2025-03-26","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11250,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001225208-25-003654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003654/doc4.xml","form_type":"4"}},{"id":1191484,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-26T20:45:26.000Z","date":"2025-03-26","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":70.8682,"value":797267.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $70.525 to $71.320. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30387,"source":{"system":"sec-edgar","filing":"0001225208-25-003654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003654/doc4.xml","form_type":"4"}},{"id":1191483,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-26T20:45:26.000Z","date":"2025-03-26","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":45.2767,"value":509362.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."}],"balance_after":41637,"source":{"system":"sec-edgar","filing":"0001225208-25-003654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003654/doc4.xml","form_type":"4"}},{"id":1239288,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-02-28T22:05:06.000Z","date":"2025-02-28","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001225208-25-002619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825002619/doc4.xml","form_type":"4"}},{"id":1239287,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T22:05:06.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":7760,"price":70.516,"value":547204.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.20 to $71.06. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30387,"source":{"system":"sec-edgar","filing":"0001225208-25-002619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825002619/doc4.xml","form_type":"4"}},{"id":1239286,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T22:05:06.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":3490,"price":71.3819,"value":249122.831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $71.23 to $71.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":38147,"source":{"system":"sec-edgar","filing":"0001225208-25-002619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825002619/doc4.xml","form_type":"4"}},{"id":1239285,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T22:05:06.000Z","date":"2025-02-28","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":45.2767,"value":509362.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."}],"balance_after":41637,"source":{"system":"sec-edgar","filing":"0001225208-25-002619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825002619/doc4.xml","form_type":"4"}},{"id":1264864,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T23:18:44.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":174,"price":76.19,"value":13257.06,"ownership":{"direct":true},"balance_after":30387,"source":{"system":"sec-edgar","filing":"0001225208-25-001908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001908/doc4.xml","form_type":"4"}},{"id":1270152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-02-13T23:04:21.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33750,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001225208-25-001712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001712/doc4.xml","form_type":"4"}},{"id":1270151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:21.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":75.7575,"value":852271.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.1900 to $76.1201. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30561,"source":{"system":"sec-edgar","filing":"0001225208-25-001712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001712/doc4.xml","form_type":"4"}},{"id":1270150,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:21.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":45.2767,"value":509362.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."}],"balance_after":41811,"source":{"system":"sec-edgar","filing":"0001225208-25-001712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001712/doc4.xml","form_type":"4"}},{"id":1318918,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-03T01:28:36.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":158,"price":142.0639,"value":22446.0962,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2024 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 4th quarter 2024 retainer fees."}],"balance_after":4891,"source":{"system":"sec-edgar","filing":"0001127602-25-000136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225000136/form4.xml","form_type":"4"}},{"id":1339477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-12-09T21:58:02.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45000,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001225208-24-010647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010647/doc4.xml","form_type":"4"}},{"id":1339476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-09T21:58:02.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":71.6805,"value":806405.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $71.290 to $71.965. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30561,"source":{"system":"sec-edgar","filing":"0001225208-24-010647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010647/doc4.xml","form_type":"4"}},{"id":1339475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-09T21:58:02.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":45.2767,"value":509362.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024."}],"balance_after":41811,"source":{"system":"sec-edgar","filing":"0001225208-24-010647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010647/doc4.xml","form_type":"4"}},{"id":1397039,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-01T21:05:50.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":183,"price":122.7793,"value":22468.6119,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2024 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 3rd quarter 2024 retainer fees."}],"balance_after":4733,"source":{"system":"sec-edgar","filing":"0001127602-24-024722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224024722/form4.xml","form_type":"4"}},{"id":1466256,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-01T20:13:22.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":205,"price":109.6538,"value":22479.029,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2024 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 2nd quarter 2024 retainer fees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Mr. Ullem's unvested RSUs were increased by 53 units as a result of such adjustment."}],"balance_after":4550,"source":{"system":"sec-edgar","filing":"0001127602-24-019543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224019543/form4.xml","form_type":"4"}},{"id":1473807,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-06-20T21:43:10.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56250,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001225208-24-006925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006925/doc4.xml","form_type":"4"}},{"id":1473806,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:43:10.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":5225,"price":87.4666,"value":457012.985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $87.065 to $87.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30561,"source":{"system":"sec-edgar","filing":"0001225208-24-006925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006925/doc4.xml","form_type":"4"}},{"id":1473805,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:43:10.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":400,"price":88.1125,"value":35245.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $88.110 to $88.115. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":35786,"source":{"system":"sec-edgar","filing":"0001225208-24-006925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006925/doc4.xml","form_type":"4"}},{"id":1473804,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:43:10.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":true,"shares":5625,"price":45.2767,"value":254681.4375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024."}],"balance_after":36186,"source":{"system":"sec-edgar","filing":"0001225208-24-006925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006925/doc4.xml","form_type":"4"}},{"id":1507650,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-21T21:09:41.000Z","date":"2024-05-21","kind":"exercise","planned":true,"acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61875,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001225208-24-006287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006287/doc4.xml","form_type":"4"}},{"id":1507649,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-21T21:09:41.000Z","date":"2024-05-21","kind":"sale","planned":true,"acquired":false,"shares":5625,"price":90.4539,"value":508803.1875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.225 to $90.720. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30561,"source":{"system":"sec-edgar","filing":"0001225208-24-006287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006287/doc4.xml","form_type":"4"}},{"id":1507648,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-21T21:09:41.000Z","date":"2024-05-21","kind":"exercise","planned":true,"acquired":true,"shares":5625,"price":45.2767,"value":254681.4375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024."}],"balance_after":36186,"source":{"system":"sec-edgar","filing":"0001225208-24-006287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006287/doc4.xml","form_type":"4"}},{"id":1512129,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-17T22:03:47.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date."}],"balance_after":4292,"source":{"system":"sec-edgar","filing":"0001127602-24-015920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224015920/form4.xml","form_type":"4"}},{"id":1519587,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:42.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1198,"price":86.72,"value":103890.56,"ownership":{"direct":true},"balance_after":30561,"source":{"system":"sec-edgar","filing":"0001225208-24-005978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005978/doc4.xml","form_type":"4"}},{"id":1522382,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2024-05-09T23:38:06.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":11075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":11075,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":11075},"source":{"system":"sec-edgar","filing":"0001225208-24-005885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005885/doc4.xml","form_type":"4"}},{"id":1522381,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:38:06.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":65500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":65500,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":65500},"source":{"system":"sec-edgar","filing":"0001225208-24-005885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005885/doc4.xml","form_type":"4"}},{"id":1522380,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:06.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":790,"price":85.09,"value":67221.1,"ownership":{"direct":true},"balance_after":31759,"source":{"system":"sec-edgar","filing":"0001225208-24-005885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005885/doc4.xml","form_type":"4"}},{"id":1522379,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:06.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":11075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":32549,"source":{"system":"sec-edgar","filing":"0001225208-24-005885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005885/doc4.xml","form_type":"4"}},{"id":1526693,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2024-05-06T23:18:32.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":7465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":7465},"source":{"system":"sec-edgar","filing":"0001225208-24-005707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005707/doc4.xml","form_type":"4"}},{"id":1526692,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:32.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4431,"price":85.25,"value":377742.75,"ownership":{"direct":true},"balance_after":21474,"source":{"system":"sec-edgar","filing":"0001225208-24-005707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005707/doc4.xml","form_type":"4"}},{"id":1526691,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:32.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":7465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":25905,"source":{"system":"sec-edgar","filing":"0001225208-24-005707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005707/doc4.xml","form_type":"4"}},{"id":1526690,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:32.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":634,"price":85.06,"value":53928.04,"ownership":{"direct":true},"balance_after":18440,"source":{"system":"sec-edgar","filing":"0001225208-24-005707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005707/doc4.xml","form_type":"4"}},{"id":1533096,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-30T20:56:53.000Z","date":"2024-04-30","kind":"exercise","planned":true,"acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001225208-24-005397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005397/doc4.xml","form_type":"4"}},{"id":1533095,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-30T20:56:53.000Z","date":"2024-04-30","kind":"sale","planned":true,"acquired":false,"shares":6550,"price":85.7373,"value":561579.315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $85.350 to $86.350. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19074,"source":{"system":"sec-edgar","filing":"0001225208-24-005397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005397/doc4.xml","form_type":"4"}},{"id":1533094,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-30T20:56:53.000Z","date":"2024-04-30","kind":"sale","planned":true,"acquired":false,"shares":700,"price":86.4036,"value":60482.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $86.375 to $86.470. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25624,"source":{"system":"sec-edgar","filing":"0001225208-24-005397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005397/doc4.xml","form_type":"4"}},{"id":1533093,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-30T20:56:53.000Z","date":"2024-04-30","kind":"exercise","planned":true,"acquired":true,"shares":7250,"price":36.75,"value":266437.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":26324,"source":{"system":"sec-edgar","filing":"0001225208-24-005397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005397/doc4.xml","form_type":"4"}},{"id":1554235,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-02T21:09:28.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":163,"price":137.682,"value":22442.166,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Ullem elected to receive 100% of his 2024 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 1st quarter 2024 retainer fees."}],"balance_after":1670,"source":{"system":"sec-edgar","filing":"0001127602-24-011920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224011920/form4.xml","form_type":"4"}},{"id":1556856,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-01T22:55:43.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":7255,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7250,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7255},"source":{"system":"sec-edgar","filing":"0001225208-24-004692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004692/doc4.xml","form_type":"4"}},{"id":1556855,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-01T22:55:43.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":6387,"price":94.8052,"value":605520.8124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $94.38 to $95.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19074,"source":{"system":"sec-edgar","filing":"0001225208-24-004692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004692/doc4.xml","form_type":"4"}},{"id":1556854,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-01T22:55:43.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":868,"price":95.51,"value":82902.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":25461,"source":{"system":"sec-edgar","filing":"0001225208-24-004692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004692/doc4.xml","form_type":"4"}},{"id":1556853,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-01T22:55:43.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":7255,"price":36.75,"value":266621.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":26329,"source":{"system":"sec-edgar","filing":"0001225208-24-004692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004692/doc4.xml","form_type":"4"}},{"id":1610784,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-29T22:12:21.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":false,"shares":7255,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14505,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7255},"source":{"system":"sec-edgar","filing":"0001225208-24-003305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003305/doc4.xml","form_type":"4"}},{"id":1610783,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:12:21.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":7255,"price":85.5855,"value":620922.8025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.02 to $86.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19074,"source":{"system":"sec-edgar","filing":"0001225208-24-003305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003305/doc4.xml","form_type":"4"}},{"id":1610782,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:12:21.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":true,"shares":7255,"price":36.75,"value":266621.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":26329,"source":{"system":"sec-edgar","filing":"0001225208-24-003305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003305/doc4.xml","form_type":"4"}},{"id":1639248,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-16T23:40:49.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":174,"price":86.04,"value":14970.96,"ownership":{"direct":true},"balance_after":19074,"source":{"system":"sec-edgar","filing":"0001225208-24-002345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002345/doc4.xml","form_type":"4"}},{"id":1664276,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-01T22:52:27.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":7255,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21760,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7255},"source":{"system":"sec-edgar","filing":"0001225208-24-001384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001384/doc4.xml","form_type":"4"}},{"id":1664275,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-01T22:52:27.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":7255,"price":78.29,"value":567993.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":19248,"source":{"system":"sec-edgar","filing":"0001225208-24-001384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001384/doc4.xml","form_type":"4"}},{"id":1664274,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-01T22:52:27.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":7255,"price":36.75,"value":266621.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":26503,"source":{"system":"sec-edgar","filing":"0001225208-24-001384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001384/doc4.xml","form_type":"4"}},{"id":1698175,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-29T21:25:52.000Z","date":"2023-12-29","kind":"exercise","planned":true,"acquired":false,"shares":14510,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29015,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":14510},"source":{"system":"sec-edgar","filing":"0001225208-23-011362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011362/doc4.xml","form_type":"4"}},{"id":1698174,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-29T21:25:52.000Z","date":"2023-12-29","kind":"sale","planned":true,"acquired":false,"shares":14510,"price":76.5537,"value":1110794.187,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.25 to $76.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19248,"source":{"system":"sec-edgar","filing":"0001225208-23-011362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011362/doc4.xml","form_type":"4"}},{"id":1698173,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-29T21:25:52.000Z","date":"2023-12-29","kind":"exercise","planned":true,"acquired":true,"shares":14510,"price":36.75,"value":533242.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023."}],"balance_after":33758,"source":{"system":"sec-edgar","filing":"0001225208-23-011362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011362/doc4.xml","form_type":"4"}},{"id":1728525,"issuer":{"id":80192,"kind":"organization","name":"BERRY GLOBAL GROUP, INC.","symbol":"BERY"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-11-28T21:32:33.000Z","date":"2023-11-25","kind":"exercise","planned":true,"acquired":false,"shares":1970,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of BERY common stock.  This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of BERY common stock.  This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award was granted on November 25, 2022 and vested in full on November 25, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award was granted on November 25, 2022 and vested in full on November 25, 2023."}],"balance_after":1393,"derivative":{"underlying":"Common Stock","underlying_shares":1970},"source":{"system":"sec-edgar","filing":"0001378992-23-000124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446989/000137899223000124/form4.xml","form_type":"4"}},{"id":1728524,"issuer":{"id":80192,"kind":"organization","name":"BERRY GLOBAL GROUP, INC.","symbol":"BERY"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-28T21:32:33.000Z","date":"2023-11-25","kind":"exercise","planned":true,"acquired":true,"shares":1970,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of BERY common stock.  This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":4728,"source":{"system":"sec-edgar","filing":"0001378992-23-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446989/000137899223000124/form4.xml","form_type":"4"}}],"next_cursor":"2023-11-28T21:32:33.000000Z,1728524"}